Antiproliferative Water-Soluble Mono- and Binuclear Ruthenium Complexes with Pyridone-Imidazole Ligands

Area of Science:

• Coordination Chemistry
• Medicinal Chemistry
• Materials Science

Background:

• Development of novel metallodrugs for cancer therapy.
• Need for water-soluble and less cytotoxic anticancer agents.
• Exploration of ruthenium complexes for biomedical applications.

Purpose of the Study:

• Synthesize and characterize novel water-soluble imidazole-pyridone ruthenium complexes (metallacycles).
• Evaluate the antiproliferative activity and cytotoxicity of these compounds against cancer cell lines and normal fibroblasts.
• Investigate the properties of binuclear metallacycles, including water solubility, hydrolytic stability, and apoptosis induction in tumor cells.

Main Methods:

• Synthesis and characterization of imidazole-pyridone ligands and ruthenium complexes.
• In vitro antiproliferative activity assessment using the MTT assay.
• Cytotoxicity evaluation on human cancer cell lines and primary rat fibroblasts.
• Analysis of water solubility, hydrolytic stability, and apoptosis induction for binuclear complexes.

Main Results:

• Successful synthesis of novel water-soluble mononuclear and binuclear ruthenium metallacycles.
• Complete absence of cytotoxicity observed for all compounds up to 1000 µM against cancer cells and fibroblasts.
• Demonstrated potential for binuclear metallacycles to induce apoptosis in tumor cells.

Conclusions:

• The synthesized ruthenium metallacycles represent a new class of water-soluble compounds with significant antiproliferative potential.
• The observed lack of cytotoxicity highlights their potential for targeted cancer therapy with reduced side effects.
• Binuclear metallacycles show promise for further development as apoptosis-inducing anticancer agents.